The TRIPS Agreement introduced a minimum global standard for the protection and enforcement of nearly all categories of intellectual property rights: patents, trademarks, copyrights, and undisclosed information, including those applying to Pharmaceuticals. The Agreement was the result of a decade-long campaign by a coalition of industries in the United States and other developed countries that united to secure a new international system for the protection of intellectual property that could be enf...